South Korea regulates the manufacture of biologics through the Ministry of Food and Drug Safety (MFDS). Manufacturers must adhere to Good Manufacturing Practice (GMP) standards specific to biologics, ensuring product safety, efficacy, and quality. This involves stringent control of raw materials, production processes, and quality testing, with regular inspections and audits for compliance.
